Emblem and Canntab Therapeutics Announce Health Canada Approval for R&D of Cannabinoid-Based Oral Sustained Release Formulation Cannabis Investing News
Precision Therapeutics Projects Meaningful STREAMWAY System Sales in Europe in the Second Half of 2018 Medical Device Investing
MediciNova Announces Opening of Investigational New Drug Application for MN-166 (ibudilast) in Glioblastoma Pharmaceutical Investing
Cellectar Granted Orphan Drug Designation for CLR 131 to Treat Rhabdomyosarcoma Pharmaceutical Investing
